Piper Sandler Issues Pessimistic Forecast for Zoetis (NYSE:ZTS) Stock Price

Zoetis (NYSE:ZTS) had its price target trimmed by Piper Sandler from $210.00 to $200.00 in a report published on Monday,Benzinga reports. The brokerage currently has an overweight rating on the stock.

A number of other equities research analysts also recently commented on ZTS. UBS Group began coverage on Zoetis in a research report on Monday, December 9th. They set a “neutral” rating and a $196.00 price objective for the company. Morgan Stanley reduced their target price on Zoetis from $248.00 to $243.00 and set an “overweight” rating for the company in a report on Wednesday, January 29th. Stifel Nicolaus dropped their price target on Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a research note on Tuesday, January 7th. Leerink Partners assumed coverage on shares of Zoetis in a research note on Monday, December 2nd. They set an “outperform” rating and a $215.00 price objective for the company. Finally, Leerink Partnrs raised shares of Zoetis to a “strong-buy” rating in a research report on Monday, December 2nd. One analyst has rated the stock with a hold rating, ten have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, Zoetis currently has an average rating of “Buy” and an average price target of $214.00.

Zoetis Stock Performance

Shares of ZTS opened at $171.71 on Monday. Zoetis has a 12-month low of $144.80 and a 12-month high of $200.53. The stock has a market capitalization of $77.47 billion, a P/E ratio of 32.28, a P/E/G ratio of 2.77 and a beta of 0.90. The firm’s 50 day moving average is $169.26 and its 200-day moving average is $179.21. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.69 and a quick ratio of 2.27.

Zoetis Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 3rd. Shareholders of record on Monday, April 21st will be paid a $0.50 dividend. The ex-dividend date is Monday, April 21st. This represents a $2.00 annualized dividend and a yield of 1.16%. Zoetis’s dividend payout ratio is presently 37.59%.

Institutional Investors Weigh In On Zoetis

Institutional investors have recently modified their holdings of the stock. Atlantic Edge Private Wealth Management LLC raised its holdings in shares of Zoetis by 482.8% during the fourth quarter. Atlantic Edge Private Wealth Management LLC now owns 169 shares of the company’s stock worth $28,000 after acquiring an additional 140 shares in the last quarter. Rakuten Securities Inc. raised its stake in shares of Zoetis by 5,533.3% during the 4th quarter. Rakuten Securities Inc. now owns 169 shares of the company’s stock worth $28,000 after purchasing an additional 166 shares in the last quarter. Darwin Wealth Management LLC acquired a new stake in shares of Zoetis during the 3rd quarter valued at about $31,000. First Personal Financial Services bought a new stake in shares of Zoetis in the 3rd quarter valued at approximately $33,000. Finally, Capital Performance Advisors LLP acquired a new position in Zoetis in the third quarter worth approximately $33,000. Institutional investors and hedge funds own 92.80% of the company’s stock.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.